⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

CNC · Centene Corporation

$64.08 latest stored close
Detected setup Power Play

Watch · Quality 22/100

2 independent risk warnings also present. Review before relying on the bullish setup.

Ask about CNC

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Health Services / CNC

$CNC

Centene Corporation

Centene Corporation is a large-cap Managed Health Care company in the Health Services sector with a market cap of $32B.

Neutral · 60 Health Services Managed Health Care stock Stage 2 · Advancing Base 3+ Data 1h 57m ago
$64.08 latest close
Council read · 6 methods

Watch — evidence is building

0 buyable · 6 watch · 0 avoid. Review the observed passes and blockers before reading the chart.

Earnings-risk mode

Pre-earnings setup

Tuesday, July 28, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

CNC+1.06%
Broad market · SPY+0.02%
Same completed session window ending 2026-07-27. +1.04 points vs SPY.
CatalystUnavailable Stock reactionPositive Sector reactionUnavailable Opening surgeUnavailable Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $64.08 Jul 27 close
52W High $69.36 -7.6%
52W Low $25.08
Wks Since High 1w
Base Depth -9.8%
Base B3
SMA 50 $63.33
SMA 200 $46.10
Avg Vol 4,862,601
RS Rank 96
RS vs High -5.4%
RS Slope -0.5% ▼
Grp Rank #17/64
ADR% 3.4%
ATR(14) $2.44 (3.8%)
Rel Vol (today) 1.41×
Vol Pace N/A
U/D Vol 0.60
A/D Days 20A / 15D
A/D Rating A+
VDU Bars 0/10 d
Earnings TODAY
$25.08
$69.36 88%

CNC Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for CNC.

Create Free Account
Setup Quality B 4/7 signals
Jul 23: 65 (Power Play)Jul 24: 55 (Power Play)Jul 27: 55 (High Tight Flag)Jul 28: 55 (Power Play)55 Score trend
✓ Stage 2 · Advancing ✗ Power Trend ✗ RS New High ✓ Trend 8/8 ✗ No Pattern ✓ CANSLIM 74.4 (B) ✓ Gatekeeper Base #3 (C)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$CNC · $64.08 · as of 2026-07-27 · multi-factor read
60
/ 100
Neutral

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▲ Uptrend

Moving Averages

50-day$63.33 ↑
100-day$52.30 ↑
200-day$46.10 ↑
Bullish (50 > 200)

RSI (14)

Reading47.9 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-0.665

Weakening — MACD slipped below its signal line. Histogram expanding.

Bollinger Bands (20,2)

%B / Width19% · 10.3%
Squeeze — volatility compressing

Near the lower band — under pressure or oversold. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.6 · Distribution
Rel volume1.41×

Distribution — volume is concentrated on down days; sellers dominate. Recent volume is easing versus its baseline.

Support & Resistance

R · $66.55swing level
R · $69.3352-week high
Price · $64.08now
S · $63.20swing level
S · $59.90swing level
S · $56.74swing level

Fibonacci · Uptrend swing

23.6%$60.46
38.2%$54.95
50.0%$50.49
61.8%$46.04
78.6%$39.70

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for CNC — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Monthly uptrendAbove 200-day MA50/200 bullishVolume distributionRS 95 (leader)
Want this read in a legend's voice? 💬 Ask a Legend about CNC
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 6 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B

Trend-template read: 11/13 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $64.08, MA150 $49.15, MA200 $46.10
1.2 150-day MA > 200-day MAMA150 $49.15 vs MA200 $46.10
Failing evidence
2. ROE ≥ 17%ROE -28.7%
2. Revenue growth ≥ 20% YoY+19.4% YoY
11/13 checks
Watch
O'Neil C

CANSLIM read: 5/8 pass; improvement is still needed.

Passing evidence
C: Quarterly EPS acceleration ≥ 25%+383.2% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 95
Failing evidence
A: Annual earnings & revenue qualityRev +19.4% | ROE -28.7%
M: Market in confirmed uptrendMarket phase: uptrend_under_pressure
5/8 checks
Watch
Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $64.08 vs MA200 $46.10
Failing evidence
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
6/7 checks
Watch
Livermore B

Pivotal-point read: 5/6 structural checks pass; awaiting volume confirmation.

Passing evidence
Price$64.08
Relative strengthRS 95
Failing evidence
Pivotal point cleared on expanding volumeNot confirmed
5/6 checks
Watch
Darvas B

Box-theory read: 5/6 structural checks pass; awaiting volume confirmation.

Passing evidence
Price$64.08
Relative strengthRS 95
Failing evidence
Box top broken on heavy volumeNot confirmed
5/6 checks
Watch
Wyckoff B

Supply-and-demand read: 5/6 structural checks pass; awaiting volume confirmation.

Passing evidence
Price$64.08
Relative strengthRS 95
Failing evidence
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
5/6 checks
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
206RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +5 A+
A: 20 D: 15 Net: +565 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 4/7 met
B 4/7 SEPA
Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ +383%
Revenue growth ≥20% YoY +19%
Gross margin ≥30% 7%
ROE ≥17% -29%
RS rating ≥80 (leadership) 95
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -7.6%

Method Playbook

📋 Trade it like Weinstein EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
Weinstein B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Power Play ⚠ 3rd-stage base ⚠ Bearish RSI divergence ⚠ Rising wedge (broke lower)
55.0 score
RS Score 95
Trend 8/8
CANSLIM 74.4* (B)
prior advance: 0.827 base depth: 0.1 num contractions: 1 is tightening: ✗ tightening waived: ✓ volume dry up: ✓ in stage2: ✓ near pivot: ✗ right side recovery: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly trend template 7/8 confirmed
Why This Setup?
Power Play

prior_advance=82.7%, base_depth=10.0%, contractions=1, tightening=waived (depth<10%), vol_dry=yes, stage2=yes, near_pivot=no | Strong trend (8/8) | Top RS (95) | High-confidence pattern (95%) | Stage 2 | Readiness 77/100 (watch) | CANSLIM 74.4 (B) | ⚠ 3rd-stage base; Bearish RSI divergence; Rising wedge (broke lower)

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

2/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

8/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $64.08 vs SMA150 $49.15 / SMA200 $46.10
SMA 150 above SMA 200 SMA150 $49.15 vs SMA200 $46.10
SMA 200 trending up Slope +3.19 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $63.33
Price above SMA 50 $64.08 vs SMA50 $63.33
30%+ above 52W low +155.5% from $25.08
Within 25% of 52W high -7.6% from $69.36
RS score above 70 RS 95

Fundamentals

52W Range
88%
Mkt Cap SEC
31.7B
EPS QoQ
+383%
Rev YoY
+19%
ROE
-29%
Gross Margin
7%
D/E
0.87
EPS TTM
$-13.53
Float
494M
Insider
No Buy

Company

Legend AI snapshot
Centene Corporation
CNC · NYSE · Health Services · Managed Health Care
$64.08latest close $31.7Bmarket cap 96RS rank 55setup score
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 74.4* CANSLIM * disqualified on C, M
C · Curr. EPS
40
A · Annual EPS
47
N · New Highs
100
S · Supply/Demand
100
L · Leader RS
95
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
100
W. Support
$31.63
W. Resist
$69.36
Weekly Structure

Scan History

Jul 23: 65 (Power Play)Jul 24: 55 (Power Play)Jul 27: 55 (High Tight Flag)Jul 28: 55 (Power Play)55
Jul 28
Power Play ✓ Gate
55
Jul 27
High Tight Flag ✓ Gate
55 0.0%
Jul 24
Power Play ✓ Gate
55 +1.1%
Jul 23
Power Play ✓ Gate
65 +0.5%

Get the full picture on CNC

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial